These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31208371)

  • 21. Establishment of Monoclonal Antibody PMab-202 Against Horse Podoplanin.
    Furusawa Y; Yamada S; Itai S; Sano M; Nakamura T; Yanaka M; Handa S; Mizuno T; Maeda K; Fukui M; Harada H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):233-237. PubMed ID: 30362932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of Mouse Monoclonal Antibody LpMab-13 Against Human Podoplanin.
    Ogasawara S; Kaneko MK; Honma R; Oki H; Fujii Y; Takagi M; Suzuki H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):155-62. PubMed ID: 27328060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity.
    Kaneko MK; Yamada S; Nakamura T; Abe S; Nishioka Y; Kunita A; Fukayama M; Fujii Y; Ogasawara S; Kato Y
    Cancer Med; 2017 Apr; 6(4):768-777. PubMed ID: 28332312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal Antibody LpMab-9 Recognizes O-glycosylated N-Terminus of Human Podoplanin.
    Kaneko MK; Oki H; Hozumi Y; Liu X; Ogasawara S; Takagi M; Goto K; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):310-7. PubMed ID: 26492618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Epitope of PMab-210 Is Located in Platelet Aggregation-Stimulating Domain-3 of Pig Podoplanin.
    Kaneko MK; Sayama Y; Sano M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2019 Dec; 38(6):271-276. PubMed ID: 31663836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope Mapping of Monoclonal Antibody PMab-233 Against Tasmanian Devil Podoplanin.
    Sano M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2019 Dec; 38(6):261-265. PubMed ID: 31621497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
    Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
    Li X; Li Z; Li X; Liu B; Liu Z
    BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.
    Feng C; Yu A; Wang Z; Wang K; Chen J; Wu Y; Deng T; Chen H; Hou Y; Ma S; Dai X; Huang L
    J Exp Clin Cancer Res; 2024 Jan; 43(1):9. PubMed ID: 38167452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of Novel Monoclonal Antibody PMab-32 Against Rabbit Podoplanin.
    Honma R; Fujii Y; Ogasawara S; Oki H; Liu X; Nakamura T; Kaneko MK; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):41-7. PubMed ID: 26788987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Podoplanin for the Treatment of Osteosarcoma.
    Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
    Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis.
    Takagi S; Oh-hara T; Sato S; Gong B; Takami M; Fujita N
    Int J Cancer; 2014 Jun; 134(11):2605-14. PubMed ID: 24222607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies.
    Nakazawa Y; Takagi S; Sato S; Oh-hara T; Koike S; Takami M; Arai H; Fujita N
    Cancer Sci; 2011 Nov; 102(11):2051-7. PubMed ID: 21824222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2.
    Ogasawara S; Kaneko MK; Price JE; Kato Y
    Hybridoma (Larchmt); 2008 Aug; 27(4):259-67. PubMed ID: 18707544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal Antibodies Directed against Cadherin RGD Exhibit Therapeutic Activity against Melanoma and Colorectal Cancer Metastasis.
    Bartolomé RA; Aizpurua C; Jaén M; Torres S; Calviño E; Imbaud JI; Casal JI
    Clin Cancer Res; 2018 Jan; 24(2):433-444. PubMed ID: 28916526
    [No Abstract]   [Full Text] [Related]  

  • 37. Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation.
    Miyata K; Takemoto A; Okumura S; Nishio M; Fujita N
    Sci Rep; 2017 Jun; 7(1):4059. PubMed ID: 28642617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity.
    Kaneko MK; Kunita A; Abe S; Tsujimoto Y; Fukayama M; Goto K; Sawa Y; Nishioka Y; Kato Y
    Cancer Sci; 2012 Nov; 103(11):1913-9. PubMed ID: 22816430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice.
    Tsukiji N; Osada M; Sasaki T; Shirai T; Satoh K; Inoue O; Umetani N; Mochizuki C; Saito T; Kojima S; Shinmori H; Ozaki Y; Suzuki-Inoue K
    Blood Adv; 2018 Sep; 2(17):2214-2225. PubMed ID: 30190281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor podoplanin: from discovery to drug development.
    Takemoto A; Miyata K; Fujita N
    Cancer Metastasis Rev; 2017 Jun; 36(2):225-234. PubMed ID: 28674748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.